Osaic Holdings’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,130
Closed -$163K 7734
2022
Q3
$163K Sell
3,130
-2,390
-43% -$98.8K ﹤0.01% 3943
2022
Q2
$137K Sell
5,520
-1,040
-16% -$22.9K ﹤0.01% 4147
2022
Q1
$212K Sell
6,560
-12,117
-65% -$341K ﹤0.01% 3987
2021
Q4
$680K Buy
18,677
+13,216
+242% +$464K ﹤0.01% 2763
2021
Q3
$94K Sell
5,461
-1,164
-18% -$18.1K ﹤0.01% 4586
2021
Q2
$88K Buy
6,625
+5,762
+668% +$142K ﹤0.01% 4589
2021
Q1
$45K Buy
863
+8
+0.9% +$481 ﹤0.01% 4964
2020
Q4
$52K Buy
855
+766
+861% +$43.9K ﹤0.01% 4539
2020
Q3
$5K Buy
+89
New +$4.79K ﹤0.01% 5603
2020
Q2
Sell
-1,161
Closed -$47K 6434
2020
Q1
$47K Buy
+1,161
New +$49.3K ﹤0.01% 4030

Other funds holding CCXI

Osaic Holdings's CCXI Position: Q4 2022 in Review

Osaic Holdings sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 3,130 shares — an estimated $163K sold.

Osaic Holdings first reported a position in CCXI in Q1 2020 and held it in 10 quarters. The position peaked at $680K in Q4 2021. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Osaic Holdings reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Osaic Holdings sold 3,130 ChemoCentryx, Inc. shares in Q4 2022, an estimated $163K.
  • Osaic Holdings first reported a position in ChemoCentryx, Inc. in Q1 2020 and held it in 10 quarters.
  • Osaic Holdings's ChemoCentryx, Inc. position peaked at $680K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Osaic Holdings's 13F filing for Q4 2022, filed 10 Feb 2023.